Functional reconstitution of KCl-evoked, Ca(2+)-dependent acetylcholine release system in Xenopus oocytes microinjected with presynaptic plasma membranes and synaptic vesicles.
We have developed a new method for the generation of functionally active presynaptic chimeras in Xenopus laevis oocytes. Frog oocytes injected with presynaptic subcellular fractions extracted from the electric organ of Torpedo marmorata release acetylcholine in a calcium-dependent manner upon chemical stimulation. Neither oocytes injected without presynaptic plasma membranes nor oocytes injected with ghost erythrocyte plasma membrane instead of presynaptic plasma membrane release acetylcholine. This suggests that specific presynaptic components necessary for KCl-evoked, Ca(2+)-dependent acetylcholine release become functionally integrated in the Xenopus laevis oocytes. Moreover, rhodaminated presynaptic plasma membranes and the synaptic vesicle protein synaptophysin are detected on the oocyte surface by fluorescence or immunofluorescence, respectively, showing that the injected presynaptic components are incorporated into the membrane of the frog oocyte. Furthermore, Botulinum neurotoxin type A, a specific blocker of acetylcholine release in the neuromuscular junction, inhibits the neurotransmitter release from the chimerical oocytes. This suggests that targets for toxin action are also functionally incorporated in the oocyte upon injection of membranous presynaptic components. Our results show that oocytes injected with presynaptic components behave as cholinergic nerve ending chimeras, at least in terms of neurotransmitter release and toxin targets. The system bypasses some problems associated with messenger RNA expression because not only proteins, but native presynaptic components are incorporated. This new technique may provide a useful approach for electrophysiological and pharmacological studies in order to characterize the synaptic transmission.
Canals
J M
JM
Departament de Biología Cellular i Anatomia Patológica, Facultat de Medicina, Hospital de Bellvitge, Universitat de Barcelona, Spain.
Ruiz-Avila
L
L
Cantí
C
C
Solsona
C
C
Marsal
J
J
D000109:Acetylcholine / Q000378:metabolism*; D000818:Animals; D001905:Botulinum Toxins / Q000633:toxicity*; D002118:Calcium / Q000494:pharmacology*; D002678:Chimera; D005260:Female; D007150:Immunohistochemistry; D008561:Membrane Fusion; D051379:Mice; D008845:Microinjections; D009498:Neurotoxins / Q000633:toxicity; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D011189:Potassium Chloride / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis; D013570:Synaptic Membranes / Q000502:physiology*; D013572:Synaptic Vesicles / Q000502:physiology*; D016708:Synaptophysin / Q000032:analysis; D014020:Tissue Extracts / Q000494:pharmacology; D014101:Torpedo; D014982:Xenopus laevis
D009498:Neurotoxins; D012333:RNA, Messenger; D016708:Synaptophysin; D014020:Tissue Extracts; D011189:Potassium Chloride; D001905:Botulinum Toxins; D000109:Acetylcholine; D002118:Calcium